A London-based start-up employs bioprospectors to scour the world for DNA to feed AI models building a digital tree of life ...

RevivBio, a trailblazing biotech company Redefining Biologics and Biosensors development, welcomes Dr. Ron Meeusen to its Board of Directors. Dr. Meeusen is a renowned leader in biotechnology, with a ...

The U.S. Food and Drug Administration (FDA) has been ahead of the curve for a number of years on emerging issues and ...

A great smile is everything! In celebration of National Smile Day, Pop On Veneers®?the fastest-growing name in custom removable cosmetic veneers?is turning up the volume on self-confidence with an ...

Quality of Life Matters: It Is Time to Integrate Scalp Cooling in Routine Clinical Practice There is a clear economic incentive for dose rounding down to a vial size to reduce product wastage.

Yet, despite the immense potential of the field, biologics have remained largely untapped. Now, amid a wave of innovation, investors and drugmakers are putting their weight behind the drug class.

Biologics are incredibly powerful and targeted. For these reasons, pharmaceutical companies have invested a lot of time and money over the past 20 years developing medications based on these ...

The Biocon Biologics Global PLC-Bond has a maturity date of 10/9/2029 and offers a coupon of 6.6700%. The payment of the coupon will take place 2,0 times per biannual on the 09.04.. The Biocon ...

Switching among biologic therapies is common practice in patients with rheumatoid arthritis who have an inadequate response or intolerable adverse events. Evidence from observational studies and ...

Expert Rev Pharmacoeconomics Outcomes Res. 2012;12(3):319-333. The most recent biologic therapy to receive marketing approval, tocilizumab, was evaluated in a 24-week, randomized, placebo ...